Citadel Advisors’s Trueblue TBI Stock Holding History
Bought
Maintained
Sold
Other funds holding TBI
RA
VCM
ACM
Citadel Advisors's TBI Position: Q1 2026 in Review
Citadel Advisors increased its Trueblue (TBI) stake by 115% in Q1 2026, buying an estimated $77.4K and bringing the position to 32,617 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #11823.
Citadel Advisors first reported a position in TBI in Q2 2013 and has held it in 46 quarters since. The position peaked at $8.35M in Q1 2024. 105 funds tracked by Wall St. Rank hold TBI as of Q1 2026.
- Citadel Advisors held 32,617 shares of Trueblue worth $128K as of Q1 2026.
- Citadel Advisors bought 17,418 Trueblue shares in Q1 2026, an estimated $77.4K.
- Trueblue made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11823 holding.
- Citadel Advisors first reported a position in Trueblue in Q2 2013 and has held it in 46 quarters since.
- Citadel Advisors's Trueblue position peaked at $8.35M in Q1 2024.
- 105 funds tracked by Wall St. Rank held Trueblue as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.